Palivizumab - AstraZeneca
At a glance
- Drug Originator MedImmune
- Drug Licenced by AbbVie; Sumitomo Pharma; Swedish Orphan Biovitrum
- Drug Class Antivirals; Monoclonal antibodies
- Mechanism of Action Viral fusion protein inhibitors
- USA Patent Applicants SWEDISH ORPHAN
- USA Patents 171
- BLAs 1
- International Patents 2,337

Disclaimer